| adalimumab mode of action | 0.37 | 0.2 | 1163 | 25 | 85 |
| adalimumab mode of action pathway | 0.57 | 0.2 | 2160 | 33 | 53 |
| mechanism of action of adalimumab | 1.86 | 0.3 | 9344 | 33 | 67 |
| adalimumab onset of action | 1.87 | 1 | 1066 | 26 | 70 |
| parameter adalimumab mechanism of action | 1.2 | 0.4 | 1933 | 40 | 77 |
| how does adalimumab work | 1.28 | 0.9 | 1529 | 24 | 67 |
| hemoglobin adalimumab mechanism of action | 0.62 | 0.5 | 9260 | 41 | 87 |
| adalimumab route of administration | 1.22 | 0.4 | 8468 | 34 | 65 |
| adalimumab activity and neutralizing antibody | 0.64 | 0.2 | 3561 | 45 | 32 |
| infliximab vs adalimumab mechanism of action | 1.96 | 0.3 | 1703 | 44 | 53 |
| adalimumab activity with reflex to antibody | 1.8 | 0.6 | 4655 | 43 | 93 |
| monitoring adalimumab treatment response | 1.1 | 0.8 | 951 | 40 | 16 |
| adalimumab activity and neutralizing ab | 1.73 | 0.5 | 2892 | 39 | 33 |
| what does adalimumab do | 0.57 | 0.1 | 611 | 23 | 76 |
| adalimumab type of drug | 1.87 | 0.8 | 6877 | 23 | 62 |
| how to use adalimumab safely and effectively | 1.11 | 0.5 | 4579 | 44 | 30 |
| how to give adalimumab | 1.58 | 0.4 | 8274 | 22 | 22 |
| adalimumab level and antibody | 0.5 | 0.9 | 1473 | 29 | 44 |
| anti-adalimumab | 0.81 | 0.2 | 1088 | 15 | 16 |
| does adalimumab cause immunosuppression | 1.64 | 0.1 | 348 | 39 | 17 |
| adalimumab patient information leaflet | 1.12 | 1 | 1068 | 38 | 85 |
| adalimumab-adbm | 0.93 | 0.3 | 8698 | 15 | 5 |
